A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)

NCT03933202 · clinicaltrials.gov ↗

COMPLETED

Status

291

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Cladribine Tablets

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]